Samar Kan shine Bright for Hayes at the Valley November 18, 2025 SERIOUS racegoers in Hong Kong will probably treat the nine-race programme at Happy Valley on Wednesday as the hors d’oeuvres, before a galaxy of stars including Ka Ying Rising, Romantic Warrior and Voyage Bubble serve up the main dish on Bank of China (Hong Kong) race-day at Sha Tin on Sunday. It may look like [...]
‘Hey you guys!’ A Goonies 40th anniversary pilgrimage to filming locations in Oregon November 18, 2025 The Goonies turns 40 this year. And so does lifelong fan Damien Gabet. To celebrate their birthdays, he visits the film locations in Oregon The first time I travelled to the States in 2009 I was so excited I thought I might die. I wanted to see where Disney and donuts came from so badly [...]
COP out: Big businesses swerve climate conference November 18, 2025 COP 26 in Glasgow represented a high-water mark for companies flouting their ambitious transition plans and lofty climate credentials. This year’s summit could not be more different, writes Ali Lyon. Reclining on stage at the 26th COP summit in his native Glasgow, Alan Jope was at home both literally and spiritually. The Unilever chief executive [...]
Staples Vegetables Announces Strategic Partnership with Solum Partners November 18, 2025 Leading UK food and renewable-energy producer joins forces with global agribusiness investment firm to fuel growth, innovation, and sustainability initiatives.
Artec 3D Launches Artec Studio Lite: Professional 3D Capture for Everyone November 18, 2025 Global 3D scanning leader Artec 3D has launched a new, accessible version of its software, Artec Studio Lite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118804372/en/ Designed to make Artec Studio’s professional 3D tools available to a larger audience, Artec Studio Lite pairs cutting-edge AI Photogrammetry with advanced 3D processing and analysis, [...]
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab November 18, 2025 Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20% 1,3 Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency 3
Wealthy divorcees race to leave Britain before the Budget November 18, 2025 High net worth divorcees are rushing to relocate amid rumours of wealth taxes and a raid on international assets, but it’s more complicated than they think, says Sophie Chapman Conflict resolution is a growth area and England (London in particular) undoubtedly remains a magnet for wealthy international couples seeking to resolve their disputes. Recent decisions [...]
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg November 18, 2025 Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence
British Basketball Federation ignored warnings before liquidation, says SLB owner November 17, 2025 The owner of Manchester Basketball has accused the British Basketball Federation of failing to heed the warning of Super League Basketball clubs before its collapse into liquidation. The governing body, which was responsible for running the Great Britain national teams and securing UK Sport funding for its elite programmes, appointed an insolvency firm last week. [...]
Duravant Announces Retirement of CEO Mike Kachmer, Names Jill Evanko Successor November 17, 2025 Mike Kachmer to retire following a distinguished 43-year career, including nearly 12 years as Chairman & CEO of Duravant Jill Evanko to succeed Mr. Kachmer as Duravant’s Chief Executive Officer